Work

Platelets: the next-generation ovarian cancer biomarker?

Year: 2026

Type: article

Source: Trends in cancer

DOI: 10.1016/j.trecan.2026.03.005

Authors: Amelia Janiak, Vahid Afshar-Kharghan, David G. Menter, Anil K. Sood, Sara Corvigno

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Cancer Society, Pfizer, AbbVie, Honorable Tina Brozman Foundation, Ovarian Cancer Research Fund Alliance, Ovarian Cancer Research Alliance, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute, Cancer Moonshot

Awards: G1468253849, G1747875899, G2857423382, G5170487712, G6758601457, G8541788133, G8666480440, Cancer Center Support Grant, The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer

OpenAlex ID: W7154591067

FWCI:

Cites: 17

Cited by:

Related to: 10